AC
BPMC

Athanor Capital’s Blueprint Medicines BPMC Stock Holding History

Athanor Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,237
Closed -$704K – 483
2021
Q1 		$704K Buy
7,237
+624
+9% +$62.3K 0.02% 412
2020
Q4 		$742K Buy
+6,613
New +$697K 0.02% 380
2020
Q1 		– Sell
-10,300
Closed -$825K – 187
2019
Q4 		$825K Buy
10,300
+3,500
+51% +$262K 0.04% 191
2019
Q3 		$500K Buy
6,800
+1,700
+33% +$147K 0.03% 155
2019
Q2 		$481K Buy
+5,100
New +$421K 0.06% 99

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Athanor Capital's BPMC Position: Q2 2021 in Review

Athanor Capital sold out of Blueprint Medicines (BPMC) in Q2 2021, closing a stake of 7,237 shares — an estimated $704K sold.

Athanor Capital first reported a position in BPMC in Q2 2019 and held it in 5 quarters. The position peaked at $825K in Q4 2019. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

  • Athanor Capital reported no remaining Blueprint Medicines position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 7,237 Blueprint Medicines shares in Q2 2021, an estimated $704K.
  • Athanor Capital first reported a position in Blueprint Medicines in Q2 2019 and held it in 5 quarters.
  • Athanor Capital's Blueprint Medicines position peaked at $825K in Q4 2019.
  • 281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.